Where does Futuragene Israel Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Futuragene Israel Ltd. ranks #40,337 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Futuragene Israel Ltd. hold?

Futuragene Israel Ltd. holds 6 US utility patents granted between 2018 and 2023, spanning 6 technology areas.

What is Futuragene Israel Ltd.'s Innovation Score?

Futuragene Israel Ltd. has an Innovation Score of 32.3 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Futuragene Israel Ltd.'s patent grant rate increasing or decreasing?

Futuragene Israel Ltd.'s recent grant velocity is -80% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Futuragene Israel Ltd.'s patents?

Futuragene Israel Ltd.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Futuragene Israel Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Futuragene Israel Ltd.

Q: What technology areas does Futuragene Israel Ltd. focus on?

Futuragene Israel Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents, ranking #1,557 of 4,144 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Futuragene ranks #40,337 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#40,337
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.3/100): 17.0
avg claims per patent: -80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40337 · Foreign Corporation #40,337 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,337/49,997
PHOTO-FINISH FÁBRICA Nacional DE…
CPC-NARROW C12N · 6 areas
INNOV-THIN 32.3/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: FÁBRICA Nacional DE Moneda Y TIMBRE—REAL Casa DE LA Moneda (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Futuragene’s 32.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (21%) Velocity 6.7 pts (21%) Breadth 8.7 pts (27%) Claim depth 10.2 pts (32%)

Qualcomm Incorporated · highest

85
Futuragene Israel · this assignee

32
3D Lighting… · lowest

7

What this shows Futuragene's Innovation Score is 32.3/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Futuragene?

Each dot is one of Futuragene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Futuragene’s own 17.0 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Futuragene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Futuragene's grants concentrate

Futuragene Israel Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2019. By volume, Futuragene sits between Fundacion Copec Universidad Católica and FÁBRICA Nacional DE Moneda Y TIMBRE—REAL Casa DE LA Moneda.

Futuragene's three-year grant acceleration

Futuragene Israel Ltd. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Fundacion Copec U…

6
Funkitron

6
Furious People

6
Futura IP

6
Future Technology

6
Futurity Group

6
Fydec Holding

6
FÁBrica Nacional…

6
Futuragene Israel ◀

6

What this shows Futuragene holds 6 patents at rank #40,329, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Futuragene

By rank, the assignees closest to #40,329 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Futuragene's primary technology class.

Futuragene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Futuragene Israel Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	4	66.7%
2019	1	16.7%
2023	1	16.7%

Which technologies does Futuragene Israel Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07K - Peptides 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12Y - Enzymes 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Futuragene Israel Ltd.'s patent record in context - here's where to go next.

Futuragene Israel Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #40,337 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Futuragene Israel Ltd. against Fundacion Copec Universidad Católica, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.